Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Clinical trial NCT01644773 · COMPLETED
Trial details
- NCT number
- NCT01644773
- Sponsor
- St. Jude Children's Research Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-27
- Primary completion
- 2018-03-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.